Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
BioLine RX (BLRX US)
Watchlist
9
Analysis
Health Care
•
Israel
BioLineRx Ltd. is a biopharmaceutical development company. The Company develops clinical-stage therapeutic pharmaceutical drugs.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
BioLine RX
•
02 Jun 2025 19:00
•
Issuer-paid
BLRX: First Quarter Results
BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...
Zacks Small Cap Research
Follow
208 Views
Share
bullish
•
BioLine RX
•
28 May 2025 14:00
•
Issuer-paid
BLRX: First Quarter Results
BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...
Zacks Small Cap Research
Follow
192 Views
Share
bullish
•
BioLine RX
•
03 Apr 2025 15:00
•
Issuer-paid
BLRX: 2024 Financial Results
BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...
Zacks Small Cap Research
Follow
182 Views
Share
bullish
•
BioLine RX
•
19 Feb 2025 15:00
•
Issuer-paid
BLRX: Aphexda Transition Progressing
BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...
Zacks Small Cap Research
Follow
312 Views
Share
bullish
•
BioLine RX
•
03 Dec 2024 22:00
•
Issuer-paid
BLRX: Ayrmid Assumes Commercialization Efforts
BioLineRx is a commercial stage biopharmaceutical company with a development portfolio advancing motixafortide, a platform molecule targeting...
Zacks Small Cap Research
Follow
393 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.7
x